Nanomedicines for cell reprogramming in tissue engineering and immunomodulation
Por favor, use este identificador para citas ou ligazóns a este ítem:
http://hdl.handle.net/10347/16770
Ficheiros no ítem
Metadatos do ítem
Título: | Nanomedicines for cell reprogramming in tissue engineering and immunomodulation |
Autor/a: | Martínez Ledo, Adriana |
Dirección/Titoría: | Alonso Fernández, María José García Fuentes, Marcos |
Centro/Departamento: | Universidade de Santiago de Compostela. Facultade de Farmacia Universidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica |
Palabras chave: | Nanomedicine | Biomaterials | Tissue engineering | Cancer immunotherapy | |
Data: | 2018 |
Resumo: | The main goal of this thesis has been the development of various RNA-based therapies to modulate cell phenotypes in two different disease contexts: cancer and tissue engineering. Given the poor cell-permeability of naked RNA molecules, as well as their short half-life in biorelevant media, a critical aspect of the work has been the design and development of biomaterial-based systems intended to overcome these limitations. On the one hand, we developed a nanocarrier capable of co-allocating RNAi and chemokines to revert the tumor immunosuppression mediated by myeloid derived suppressor cells. On the other hand, we investigated a new concept of gene-activated matrices (GAMs) activated with mRNA-encoded transcription factors (TFs) to direct stem cell chondrogenic and myogenic specification. We finally optimized GAM mechanics in order to enhance TF transfection and cell differentiation driven by TF overexpression. |
URI: | http://hdl.handle.net/10347/16770 |
Dereitos: | Attribution-NonCommercial-NoDerivatives 4.0 Internacional |
Coleccións
-
- Área de Ciencias da Saúde [1262]
O ítem ten asociados os seguintes ficheiros de licenza: